AI Assistant
Blog
Pricing
Log In
Sign Up
Cisplatin Plus Gemcitabine as Standard of Care for Germline
BRCA/PALB2
‐Mutated Pancreatic Adenocarcinoma: Are We Moving Too Fast?
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
